PD-L1, KIM-1 Levels May Predict Kidney Cancer Response to Opdivo, Yervoy
PD-L1 expression levels were found to predict improved outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 ...
Tag: kidney cancer treatment
Anti-PD-L1 Antibody Drug Combo May Improve Outcomes in Advanced Kidney Cancer
Anti–PD-L1 monoclonal antibody benmelstobart plus anlotinib for the frontline treatment of advanced renal cell carcinoma (RCC), a type of kidney ...
Palliative Care in Kidney Cancer More Than Just Relieving Symptoms
The timing for palliative care may be appropriate if patients are experiencing uncontrolled symptoms or prefer more support during treatment. ...
Kidney Cancer FAQs Answered on Treatments, Care Teams and More
After receiving a diagnosis of kidney cancer, it's important to understand aspects, including stage and grade, treatment options and treatment ...
Pre- and Postsurgical Opdivo Does Not Boost Relapse-Free Survival in Kidney Cancer
The recurrence-free survival was 33% in the Opdivo group and surgery-only group in certain patients with kidney cancer. Adding Opdivo ...
Study Analyzes Welireg Side Effects in Kidney Cancer
Serious side effects from Welireg treatment occurred in 41% of patients with kidney cancer, according to an analysis of four ...